NCT04769414View on ClinicalTrials.gov

Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 20, 2021

Primary Completion Date

July 9, 2022

Study Completion Date

July 9, 2022

Conditions
Cancer of PancreasChemotherapy EffectMetastatic Pancreatic Cancer
Interventions
DRUG

Gemcitabine fluorouracil

"chemotherapy protocol given as:~* Gemcitabine 1000mg/m2 IV short infusion~* Leucovorin 400 mg/m2 IV short infusion~* Flourouracil 400 mg/m2 direct IV shot~* Flourouracil 2000 mg/m2 contineous infusion over 46 hours~The whole regimen will be repeated bi-weekly"

Trial Locations (1)

32511

Menoufia University, Faculty of medicine, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT04769414 - Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | Biotech Hunter | Biotech Hunter